
A new purified Lawsoniaside remodels amyloid-β42 fibrillation into a less toxic and non-amyloidogenic pathway
Keywords: Aβ42; β-amyloid peptide42; AD; Alzheimer's disease; BSA; bovine serum albumin; CD; circular dichroism; CTX-B; cholera toxin subunit B; DLS; dynamic light scattering; DMSO; dimethyl sulfoxide; FRET; fluorescence resonance energy transfer; GM1; monosialot